Literature DB >> 290184

Using the spectral analysis of the EEG for prognosis of severe brain injuries in the first post-traumatic week.

W I Steudel, J Krüger.   

Abstract

Fifty adult patients with severe brain injuries were examined with the EEG on the 1st, 2nd, 3rd, 5th, and 7th postoperative days. In 40 of these 50 cases a prognosis was given after 7 days as a result of the Fourier analysis of the EEG: 23 patients survived, 17 died. There are significant differences in the EEG's for these two groups: an increase of the absolute and relative amplitudes in the alpha and theta bands for the survivors, and a decrease or no change in the alpha and theta bands for the others, all during the first week. In 10 cases the correct prognosis could not be given: 5 patients showed spindle or alpha activity (alpha pattern coma) in the EEG; 4 cases had to be treated with barbiturates for focal seizures, and one suffered from secondary bleeding. In these cases computer tomography did not yield additional prognostic information.

Entities:  

Mesh:

Year:  1979        PMID: 290184     DOI: 10.1007/978-3-7091-4088-8_7

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  3 in total

Review 1.  Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM.

Authors:  Jan Claassen; Fabio S Taccone; Peter Horn; Martin Holtkamp; Nino Stocchetti; Mauro Oddo
Journal:  Intensive Care Med       Date:  2013-05-08       Impact factor: 17.440

2.  Life or death: prognostic value of a resting EEG with regards to survival in patients in vegetative and minimally conscious States.

Authors:  Alexander A Fingelkurts; Andrew A Fingelkurts; Sergio Bagnato; Cristina Boccagni; Giuseppe Galardi
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

Review 3.  Electrophysiologic monitoring in acute brain injury.

Authors:  Jan Claassen; Paul Vespa
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.